The commonly held view that state tort liability litigation can do much good and little harm because it provides added protection to patients and consumers is largely unsupported.

Until government price controls are lifted, the makers of generics will be unable to cover their production costs.

Will more regulations and a more centralized food safety bureaucracy make us safer? What kind of regulations and implementation mechanisms would best serve the public's desire for ensuring food safety?

The low-sodium campaigners should focus their efforts on consumer demand, not on new FDA regulations.

The federal preemption of state tort law is an issue in several cases on the Supreme Court’s docket, including February 25 oral arguments in Warner-Lambert v. Kent. The Supreme Court also recently agreed to hear early next term appeals in the cases of Wyeth v. Levine, in which the federal...

Policies enacted over the last few decades have systematically eroded the ability of manufacturers to earn returns on certain drugs, especially older parenteral drugs sold as generics. We need to reform the policies governing these markets if we're going to lure investment back into these important areas.

The new Obama drug initiative is of a piece with the administration's abiding faith in the virtue of government investment as a trump to private entrepreneurism. At the core of this religion is a faith that that the political allocation of capital leads to better, or at least more "equitable" outcomes.